Press release
Charting a Prosperous Path: PPMS Treatment Market to Achieve Over US$ 3.2 Billion by 2031
The global primary progressive multiple sclerosis (PPMS) treatment market has witnessed substantial growth in recent years, with projections indicating a promising outlook for the future. Characterized by the progressive deterioration of nerve cells' protective covering, PPMS presents unique challenges that require innovative solutions. This article delves into the key drivers, trends, players, and future prospects of the PPMS treatment market.๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐ฎ ๐๐ฎ๐บ๐ฝ๐น๐ฒ ๐ผ๐ณ ๐๐ต๐ถ๐ ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ (๐จ๐๐ฒ ๐๐ผ๐ฟ๐ฝ๐ผ๐ฟ๐ฎ๐๐ฒ ๐ ๐ฎ๐ถ๐น ๐๐ฑ ๐ณ๐ผ๐ฟ ๐ค๐๐ถ๐ฐ๐ธ ๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ฒ) -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85270&utm_source=OpenPR_Ajay&utm_medium=OpenPR
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ข๐๐ฒ๐ฟ๐๐ถ๐ฒ๐
In 2021, the PPMS treatment market was valued at US$ 828.4 million, and it is projected to exhibit a remarkable Compound Annual Growth Rate (CAGR) of 14.7% from 2022 to 2031. This growth can be attributed to various factors, including the rise in the geriatric population and the increasing prevalence of PPMS across the globe. Governments of both developed and developing countries are actively promoting awareness of available treatment options for multiple sclerosis, thereby contributing to market expansion.
๐๐ฒ๐ ๐๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ฟ๐ถ๐๐ถ๐ป๐ด ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฟ๐ผ๐๐๐ต
Prevalence of PPMS: The prevalence of PPMS has been steadily increasing, affecting both men and women. In 2020, the National Multiple Sclerosis Society reported that approximately 2.8 million individuals were living with multiple sclerosis globally. This surge in cases drives the demand for effective drugs and medical interventions, propelling market growth.
Healthcare Expenditure: The continuous rise in healthcare expenditure, coupled with improved healthcare infrastructure, plays a vital role in expanding the PPMS treatment market. Various public and private organizations are actively promoting awareness about multiple sclerosis, thereby driving the industry forward.
Research and Development: Major players in the market are heavily investing in research and development activities to develop innovative drugs. While Roche's OCREVUS is currently available, ongoing R&D efforts aim to create more effective treatments. Numerous drugs are in clinical development, with some in advanced phases, hinting at the potential for breakthroughs in the near future.
๐๐๐ ๐๐ต๐ถ๐ ๐ฃ๐ฟ๐ฒ๐บ๐ถ๐๐บ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ | ๐๐บ๐บ๐ฒ๐ฑ๐ถ๐ฎ๐๐ฒ ๐๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐๐๐ฎ๐ถ๐น๐ฎ๐ฏ๐น๐ฒ ๐ฎ๐ -
https://www.transparencymarketresearch.com/checkout.php?rep_id=85270<ype=S&utm_source=OpenPR_Ajay&utm_medium=OpenPR
๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ฎ๐ป๐ฑ ๐๐ถ๐๐๐ฟ๐ถ๐ฏ๐๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐ป๐ป๐ฒ๐น๐
The PPMS treatment market is segmented into approved drugs and pipeline drugs based on drug type. Currently, Roche's OCREVUS dominates the approved drugs segment, while over 15 drugs are in various stages of clinical trials, suggesting a vibrant pipeline segment.
In terms of distribution channels, retail pharmacies lead the way due to favorable health reimbursement policies. The growth of online platforms in the pharmaceutical sector has also led to an upsurge in online distribution, making e-commerce a rapidly growing channel.
๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป๐ฎ๐น ๐ข๐๐๐น๐ผ๐ผ๐ธ
North America holds a significant market share, driven by a high prevalence of PPMS in the United States and a growing demand for therapeutic drugs. Asia Pacific, particularly India and China, is poised to register the highest CAGR during the forecast period due to an increasing awareness of PPMS treatment options and improving healthcare infrastructure.
๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐ฐ๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐๐ต๐ถ๐ ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ -
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85270&utm_source=OpenPR_Ajay&utm_medium=OpenPR
๐๐ฒ๐ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐๐
Prominent players in the PPMS treatment market include F. Hoffmann-La Roche Ltd., Sanofi, Mapi Pharma Ltd., Atara Biotherapeutics, Takeda Pharmaceuticals International, Inc., AB Science, and Mallinckrodt. These companies are actively engaged in research, development, and clinical trials to enhance the quality of life for PPMS patients.
๐๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฎ๐ป๐ฑ ๐๐๐๐๐ฟ๐ฒ ๐ฃ๐ฟ๐ผ๐๐ฝ๐ฒ๐ฐ๐๐
The PPMS treatment market's future is characterized by innovation and a focus on improving patients' lives. Ongoing research, emphasis on R&D activities, and a growing array of pipeline drugs indicate a promising path forward. The collaborative efforts of organizations like the International Progressive MS Alliance exemplify the dedication to finding effective treatments for PPMS and enhancing patients' quality of life.
๐ ๐ผ๐ฟ๐ฒ ๐ง๐ฟ๐ฒ๐ป๐ฑ๐ถ๐ป๐ด ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐๐ ๐ฏ๐ ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐ฎ๐ฟ๐ฒ๐ป๐ฐ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต -
Amniotic Membrane Market
https://www.globenewswire.com/en/news-release/2022/08/08/2494153/0/en/Amniotic-Membrane-Market-Attracts-Notable-Business-Avenues-with-Rising-Prevalence-of-ophthalmic-disorders-Says-TMR-Review.html
Joint Pain Injections Market
https://www.globenewswire.com/en/news-release/2022/08/08/2494104/0/en/Joint-Pain-Injections-Market-Expands-due-to-Rising-Prevalence-of-Knee-related-Diseases-States-TMR-Study.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, providesย custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contactย Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Charting a Prosperous Path: PPMS Treatment Market to Achieve Over US$ 3.2 Billion by 2031 here
News-ID: 3171399 • Views: โฆ
More Releases from Transparency Market Research
Global Pet Dietary Supplements Market Outlook 2035: Rising from USD 3.7 Billion โฆ
The global pet dietary supplements market reached US$ 3.7 billion in 2024 and is on track to nearly double by 2035, achieving a forecast valuation of US$ 7.4 billion. This growth reflects a CAGR of 6.6% from 2025 to 2035, supported by changing owner preferences, the rise of evidence-backed formulations, and greater accessibility through both online and offline retail systems. North America accounted for 31.7% of global revenue in 2024,โฆ
Beauty Devices Market Size Reaches USD 36.18 Billion in 2024 and Is Forecast to โฆ
The global beauty devices market continues to expand rapidly as consumers prioritize personal grooming, skincare, and at-home beauty solutions that offer professional-grade results. Driven by technological advancements, rising disposable incomes, and cultural emphasis on appearance, the sector is projected to experience sustained growth through 2035. According to industry estimates, the beauty devices market was valued at US$ 36,188.7 Mn in 2024 and is forecasted to reach US$ 99,873.0 Mn byโฆ
PVC Cling Films Market Outlook 2032: Global Valuation of USD 812.3 Million in 20 โฆ
The global PVC cling films market was valued at US$ 812.3 Mn in 2023 and is projected to reach US$ 1.1 Bn by 2032, expanding at a CAGR of 3.5% between 2024 and 2032. This steady growth trajectory is supported by the rising demand for sustainable packaging materials, continuous advancements in food protection technologies, and increasing consumption of packaged foods, especially across developing Asia-Pacific economies. With the surge of onlineโฆ
PVC Foam Profiles Market Outlook 2034: Global Valuation to Reach USD 4.8 Billion โฆ
The global PVC foam profiles market was valued at US$ 2.9 Bn in 2023. As industries continue to adopt lightweight, moisture-resistant, and dimensionally stable materials, PVC foam profiles are witnessing growing integration into construction, automotive, marine, and furniture manufacturing applications. According to current projections, the market is set to expand at a CAGR of 4.2% from 2024 to 2034, ultimately reaching US$ 4.8 Bn by 2034. This sustained growth reflectsโฆ
More Releases for PPMS
Primary Progressive Multiple Sclerosis (PPMS) Market is expected to reach USD 6. โฆ
Primary progressive multiple sclerosis (PPMS) is a debilitating neurological disorder that represents approximately 10-15% of all multiple sclerosis (MS) cases. Unlike relapsing-remitting MS (RRMS), which is characterized by relapses followed by partial recovery, PPMS involves a steady progression of disability without distinct relapses. Symptoms include muscle weakness, gait difficulties, spasticity, fatigue, and cognitive decline, significantly impacting quality of life.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72071
Until recently, treatmentโฆ
Emerging Trends to Drive Primary Progressive Multiple Sclerosis (PPMS) Treatment โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Primary Progressive Multiple Sclerosis (PPMS) Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size for the treatment of primary progressive multiple sclerosis (ppms) has seen significant expansion in recent years. It is set to increase from $1.02 billion in 2024 to $1.16 billion in 2025,โฆ
Primary Progressive Multiple Sclerosis Treatment Market Projected to Exhibit Gro โฆ
The global Primary Progressive Multiple Sclerosis (PPMS) Treatment Market has witnessed remarkable growth owing to several key factors, as outlined in a comprehensive research report released by Transparency Market Research. The report delves into the drivers, trends, and projections shaping the landscape of PPMS treatment across the globe.
The rise in the geriatric population coupled with a surge in the prevalence of PPMS worldwide has significantly impacted the market statistics inโฆ
Physical Property Measurement System (PPMS) Market 2023- 2029 Global Insights by โฆ
The Physical Property Measurement System (PPMS) market refers to the industry involved in the manufacturing, distribution, and sale of PPMS instruments and related services. PPMS is a sophisticated laboratory instrument used to measure various physical properties of materials at extremely low temperatures, high magnetic fields, and under different environmental conditions.
PPMS instruments are widely used in scientific research and development, particularly in fields such as materials science, condensed matter physics, chemistry,โฆ
Primary Progressive Multiple Sclerosis Market Size, Share, Epidemiology, Drugs, โฆ
DelveInsight's "Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To know more about Primary Progressive Multiple Sclerosis, Click here: https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Primary Progressive Multipleโฆ
Multiple Sclerosis Market - Opportunity Analysis & Industry Forecast, 2017-2023
Multiple sclerosis (MS) is an inflammatory disease of nervous system, which is also referred as disseminated sclerosis. Multiple sclerosis is progressed with disruption spinal cord and brain nerve cells, which results in loss of ability of the parts of the nervous system to communicate including various other mental, physical and psychiatric problems. Primary progressive multiple sclerosis (PPMS) is the type of multiple sclerosis in which neurological functions are steadily deterioratedโฆ
